Innovative Approaches to HIV Treatment and Prevention: Where We Are Now and Why We Need to Talk About Policy
- This event has passed.
Please join O’Neill Institute Senior Associate Sean Bland, JD, for a brown bag lunch discussion in recognition of World AIDS Day on innovative approaches to HIV treatment and prevention. This will include a discussion of long-acting agents, which are products under development to treat and prevent HIV infection and would not require daily dosing, and efforts to start people living with HIV on antiretroviral therapy (ART) on the same day that they receive an HIV diagnosis or are re-engaged in HIV care. For long-acting agents, policy issues we will discuss a range of policy issues, from Food and Drug Administration (FDA) approval to questions about consumer and provider acceptance, drug pricing, and the payer landscape (Medicaid, Medicare, private insurance), with attention to the Trump Administration’s plan to reduce drug prices, including altering how Medicare’s Part B program pays for certain drugs and changing Medicare’s payment system to encourage doctors toward less expensive medications. For same-day or rapid (within a few days) start of ART, we will discuss how the Ryan White HIV/AIDS Program can support making this the standard practice. We will also discuss some implications for improving sexual and reproductive health and for reducing HIV-related health disparities and health inequities.
Feel free to bring your own lunch.
Accommodation requests related to a disability should be made by November 28th to Maryangel Rodriguez, 202-662-9844, or email@example.com